Starting soon, a 4-hr event 'The State of Omics'
Hosted by Julianna LeMieux PhD Genetic Engineering & Biotechnology News
Featuring Anne Wojcicki Mike Snyder, Fei Chen, Eriona Hysolli Colossal Biosciences® and more.
Free registration:
webinars.liebertpub.com/e/the-state-of…

Excited to announce a new opportunity to join our active & amazing group Arena BioWorks! linkedin.com/jobs/view/3901… I'm hiring a Scientist to lead development & translation of new CRISPR & gene editing technologies in our multidisciplinary and highly collaborative environment. (1/2)

The future of genome editing is in vivo! Check out our latest PNASNews perspective from Doudna Lab. Had a lot of fun discussions with Kevin Wasko and Jennifer R Hamilton about the past, present, and future of in vivo delivery.

pnas.org/doi/10.1073/pn…

What’s the best system for generating inducible CRISPR knockouts in a mouse xenograft?

My lab hasn’t had great results with dox-Cas9 due to leaky expression and incomplete induction…

Looking for a deep dive into the world of genomics?

Our very own Eriona Hysolli joins Stanford University Professor and Chair, Mike Snyder (@SnyderShot), along with other leaders in the field at the State of Omics this Wednesday.

Register for free: bit.ly/3Q0CPp1

Free 4-hr virtual summit:
'The State of CRISPR and Gene Editing'
June 5, 11 am ET.
webinars.liebertpub.com/e/the-state-of…

Check out our new work by fabulous grad student Rodrigo NaturalSciences @ UT Molecular Biosciences! Guide RNA folds into gnarly geometry to tether tiny protein domains together. Fun collaboration with Metagenomi! DNA targeting by compact Cas9d and its resurrected ancestor biorxiv.org/content/10.110…

9April: How do gene editing pioneers David R. Liu and J. Keith Joung address the challenge of delivering genetic medicines--technologies being developed by newly-launched Nvelop Therapeutics? Hear from CEO Jeff Walsh & CSO Melissa Bonner, PhD in my latest for Genetic Engineering & Biotechnology News: genengnews.com/topics/genome-…

Announcing
THE STATE OF CRISPR and GENE EDITING
A free virtual summit hosted by Kevin Davies Genetic Engineering & Biotechnology News on June 5.
Confirmed speakers include:
David R. Liu
Laura Sepp-Lorenzino
Sam Sternberg
Joe Bondy-Denomy
Prof Alison Van Eenennaam (@BioBeef)
Patrick Hsu
Omar Abudayyeh
Jonathan Gootenberg
webinars.liebertpub.com/e/the-state-of…

Company News: Verve Therapeutics CEO Sek Kathiresan MD on today's PCSK9 gene editing trial pause and why he thinks a new program set to enter the clinic may avoid the issues seen. $VERV

Full video: biotechtv.com/post/verve-the…

Only 3 weeks to the first CRISPR Medicine Conference ... #CRISPR MED24 - 23-25 April - looking forward to meet the global #CRISPR medicine community in Copenhagen and discuss new discoveries, the latest data from the trials and future directions and challenges...
Registration will…

Great reporting from our colleague Jonathan D. Grinstein, PhD Genetic Engineering & Biotechnology News on Synthego decision to split into two companies >>>

Tune into GEN's next virtual summit: The State of Omics on April 17th. During this 4-hour event, leaders from the world of genome technology, analysis, NGS and multiomics offer a pulsating view of the rapid progress in this field.

To register for free:
ow.ly/LlXO50R2pcj

🚀Watch our new video featuring Jimi Olaghere as he discusses his firsthand experience and the profound impact of the pioneering approval of Casgevy, the US' first CRISPR therapy.
hubs.ly/Q02qKG-40
#Casgevy #SickleCellAwareness #CRISPRTherapeutics [Video Link] 🎥✨

What's the latest news on #CRISPR clinical trials? We've got you covered with a comprehensive (and readable!) 2024 overview. Read here & share: ow.ly/Q7M250QSvuO

Featuring insights from Fyodor Urnov and Justin Eyquem!

BEAM-302 has advanced towards a clinical trial in the UK. It’s exciting to see base editing technology continue to potentially provide solutions for patients who are suffering. Thank you to the Beam Therapeutics team & John Evans for leading the field into the future of genomic medicines

I am thrilled to announce that I will soon open my independent group at CIRI Lyon 🤩

My team will develop new approaches to explore the molecular arms race between phages and bacteria 🦠🧐

Join us in this new adventure in the beautiful city of Lyon !

A great Financial Times article in which Doudna Lab publicly calls for heavy investment in the CRISPR Gene Editing sector in order to expand medical therapies based on Gene Editing & to make them globally accessible to all. $XBI $NTLA $BEAM $CRSP $PRME $VERV $CRBU ft.com/content/756c1b…

NEW WEBINAR! On 3/26, our expert speakers will introduce NanoMosaic’s Tessie™, a fit-for-purpose platform for gene therapy applications that effectively combines protein and nucleic acid quantification in a single run. REGISTER: ow.ly/wENr50QO3PB #NanoMosaic

Excited to announce a major medical milestone today with Mass General Surgery, as we announced the first ever transplantation of a genetically engineered porcine kidney into a living human recipient. 🧬🧬

Read our release:
shorturl.at/kEGTV